Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neurofibromatosis 1 1Lymphoma, Follicular 1Acute Lung Injury 1

Interventions

Rituximab 28Lenalidomide 23Cyclophosphamide 18Prednisone 14Vincristine 12Doxorubicin 11obinutuzumab 10Magnetic Resonance Spectroscopy 10Specimen Handling 9Biopsy 8Bendamustine Hydrochloride 8ibrutinib 7pembrolizumab 6fludarabine 5zanubrutinib 4tazemetostat 4fludarabine phosphate 4Radiotherapy 4R-CHOP protocol 4Peripheral Blood Stem Cell Transplantation 4CT-P10 4venetoclax 3Prednisolone 3Etoposide 3tisagenlecleucel 2polatuzumab vedotin 2orelabrutinib 2loncastuximab tesirine 2Whole-Body Irradiation 2Temozolomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Inhalation × 90 days × Clear all
NCT07558538 2026-04-30

Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Shanghai Zhongshan Hospital

Phase EARLY_PHASE1 Not yet recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Acute Lung Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡